We have studied the clinical usefulness of Flumazenil to reverse the sedative action of Midazolam in 12 children admitted in a Pediatric Intensive Care Unit. Two groups were established, one treated with individual dose and the other treated with continuous infusion. In four cases the indication of Flumazenil was the reversion of secondary effects and in 8 cases it was elective. The average reversion time was 1.22 +/- 0.42 minutes. Flumazenil is able to reverse immediately the effects of Midazolam.

Download full-text PDF

Source

Publication Analysis

Top Keywords

flumazenil reverse
12
reverse effects
8
effects midazolam
8
[use flumazenil
4
midazolam children]
4
children] studied
4
studied clinical
4
clinical flumazenil
4
reverse sedative
4
sedative action
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!